Aurobindo Pharma’s stock prices have surged by approximately 11% in one month to reach a fresh 52-week high in June 2023. Analysts suggest that the stock may continue to rise and recommend short-term traders to purchase the stock while expecting a target of Rs 890 levels in the next six months. The stock has formed a bullish candlestick pattern on the monthly charts and the weekly scale indicates that it has recovered quickly from the support level. The Relative Strength Index (RSI) is also above 70, suggesting that a pullback might occur.
Menu